SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-13-079871
Filing Date
2013-11-01
Accepted
2013-11-01 08:30:36
Documents
3
Period of Report
2013-11-01
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a13-23259_18k.htm 8-K 23844
2 EX-99.1 a13-23259_1ex99d1.htm EX-99.1 264479
3 GRAPHIC g232591mm01i001.gif GRAPHIC 2671
  Complete submission text file 0001104659-13-079871.txt   293282
Mailing Address 7015 ALBERT EINSTEIN DRIVE COLUMBIA MD 21046
Business Address 7015 ALBERT EINSTEIN DRIVE COLUMBIA MD 21046 443-545-1819
OSIRIS THERAPEUTICS, INC. (Filer) CIK: 0001360886 (see all company filings)

IRS No.: 710881115 | State of Incorp.: MD | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32966 | Film No.: 131184323
SIC: 2836 Biological Products, (No Diagnostic Substances)